SWEDISH ORPHAN/S (OTCMKTS:SWTUY – Get Free Report) shares dropped 1.2% during mid-day trading on Monday . The stock traded as low as $24.38 and last traded at $24.38. Approximately 200 shares were traded during mid-day trading, a decline of 88% from the average daily volume of 1,665 shares. The stock had previously closed at $24.67.
SWEDISH ORPHAN/S Price Performance
The firm’s 50-day moving average is $24.38 and its 200 day moving average is $24.38. The stock has a market cap of $6.64 billion, a price-to-earnings ratio of 48.76, a price-to-earnings-growth ratio of 1.30 and a beta of 1.81.
About SWEDISH ORPHAN/S
Swedish Orphan Biovitrum AB (publ) (OTCMKTS:SWTUY) is a Stockholm-based biopharmaceutical company specializing in the development, manufacturing and commercialization of therapies for rare diseases and specialty care. The company’s portfolio spans treatments in hematology, immunology and metabolic disorders. Its research and development efforts focus on addressing unmet medical needs by advancing both proprietary and in-licensed drug candidates through clinical and regulatory pathways.
The company’s flagship offerings include clotting factor products for hemophilia, enzyme replacement therapies for lysosomal storage disorders and targeted immunomodulators for inflammatory conditions.
Recommended Stories
- Five stocks we like better than SWEDISH ORPHAN/S
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for SWEDISH ORPHAN/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWEDISH ORPHAN/S and related companies with MarketBeat.com's FREE daily email newsletter.
